logo

SaglikDanis.com

A
B
C
D
E
F
G
H
I
İ
J
K
L
M
N
O
Ö
P
Q
R
S
Ş
T
U
Ü
V
W
X
Y
Z
Prof.Dr. Soner DUMAN
Muayene Tel
:
2323904299
İşyeri adresi
:
Ankara Cad. No:231/A Bornova Ýzmir
Şehir
:
ISTANBUL
x

Özgeçmişi


Doðum Yeri Kahramanmaras
Doðum Tarihi 01/03/1968
Eðitim Bilgileri
Mezun Olduðu Okul
1992
Ege Üniversitesi Týp Fakültesi 
Izmir
1997
Ege Üniversitesi 
Ýç Hastalýklarý Asistanlýðý
Izmir
2000
Ege Üniversitesi 
Ýç Hastalýklarý Uzmanlýðý
Izmir
2000
Ege Üniversitesi 
Nefroloji Uzmanlýðý
Izmir
2004
Ege Üniversitesi 
Ýç Hastalýklarý Doçenti
Izmir
2010
Ege Üniversitesi Fen Fakültesi 
Ýstatistik Doktorasý
x

Cevapladığı Hasta soruları

x

Cevapladığı Havuz Soruları

Kayıt bulunamadı

x

Hazır Soru Cevapları

Kayıt bulunamadı

x

Makaleleri

Kayıt bulunamadı

Çalıştığı yer

x

Yayınları

x

A. MAKALELER
1. Uluslararasý hakemli dergilerde yayýnlanan makaleler (SCI & SSCI & Arts and Humanities)
1.1. Akcicek F, Ok E, Duman S, Kursad S, Unsal A, Alev M, Atabay G, Basci A. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Adv Perit Dial. 1996;12:261-265.
1.2. Sayiner A, Kursat S, Toz H, Duman S, Onal B, Tumbay E. Pseudomembranous necrotizing bronchial aspergillosis in a renal transplant recipient. Nephrol Dial Transplant. 1999 Jul;14(7):1784-1785.
1.3. Sayiner A, Ece T, Duman S, Yildiz A, Ozkahya M, Kilicaslan Z, Tokat Y. Tuberculosis in renal transplant recipients. Transplantation. 1999 Nov 15;68(9):1268-1271.
1.4. Gunal AI, Duman S, Ozkahya M, Toz H, Asci G, Akcicek F, Basci A. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001 Mar;37(3):588-593.
1.5. Duman S, Gunal AI, Sen S, Asci G, Ozkahya M, Terzioglu E, Akcicek F, Atabay G. Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution? Perit Dial Int. 2001 Mar-Apr;21(2):219-224.
1.6. Gunal AI, Duman S, Sen S, Unsal A, Terzioglu E, Akcicek F, Basci A. By reducing TGF beta 1, octreotide lessens the peritoneal derangements induced by a high glucose solution. J Nephrol. 2001 May-Jun;14(3):184-189.
1.7. Buduneli N, Sagol O, Atilla G, Duman S, Holmstrup P. Immunohistochemical analysis of epidermal growth factor receptor in cyclosporin A-induced gingival overgrowth. Acta Odontol Scand. 2001 Dec;59(6):367-371.
1.8. Duman S, Sen S, Gunal AI, Asci G, Akcicek F, Basci A. How can we standardize peritoneal thickness measurements in experimental studies in rats? Perit Dial Int. 2001;21 Suppl 3:S338-341.
1.9. Gunal AI, Karaca I, Celiker H, Ilkay E, Duman S. Paradoxical rise in blood pressure during ultrafiltration is caused by increased cardiac output. J Nephrol. 2002 Jan-Feb;15(1):42-47.
1.10. Duman S, Toz H, Asci G, Alper S, Ozkahya M, Unal I, Celik A, Ok E, Basci A. Successful treatment of post-transplant Kaposi’s sarcoma by reduction of immunosuppression. Nephrol Dial Transplant. 2002 May;17(5):892-896.
1.11. Gunal AI, Karaca I, Celiker H, Ilkay E, Duman S. Strict volume control in the treatment of nephrogenic ascites. Nephrol Dial Transplant. 2002 Jul;17(7):1248-1251.
1.12. Gunal A, Celiker H, Akpolat N, Ustundag B, Duman S, Akcicek F. By reducing production of vascular endothelial growth factor octreotide improves the peritoneal vascular alterations induced by hypertonic peritoneal dialysis solution. Perit Dial Int. 2002 May-Jun;22(3):301-306.
1.13. Ozkahya M, Toz H, Qzerkan F, Duman S, Ok E, Basci A, Mees EJ. Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol. 2002 Nov-Dec;15(6):655-660.
1.14. Sen S, Duman S, Sarsýk B, Töz H, Zeytinoðlu A. Cytomegalovirus infection in renal allograft biopsy. Annals of Saudi Medicine 2003, 23: 306-311
1.15. Toz H, Sen S, Sezis M, Duman S, Ozkahya M, Ozbek S, Hoscoskun C, Atabay G, Ok E. Comparison of tacrolimus and cyclosporin in renal transplantation by the protocol biopsies. Transplant Proc. 2004 Jan-Feb;36(1):134-136.
1.6. Duman S, Ozbek S, Sen S, Tamsel S, Toz H, Asci G, Ozkahya M, Sezis M, Ok E, Hoscoskun C. Is "zero-hour" biopsy of the transplanted kidney risky? Transplant Proc. 2004 Jan-Feb;36(1):137-138.
1.17. Toz H, Duman S, Altunel E, Sezis M, Ozbek S, Ozkahya M, Asci G, Ok E, Basci, A. Intima media thickness as a predictor of atherosclerosis in renal transplantation. Transplant Proc. 2004 Jan-Feb;36(1):156-8.
1.18. Duman S, Breberowicz A. Renin Angiotensin System and Peritoneal dialysis. Perit Dial Int. 2004 Jan-Feb;24(1):1-4 (Editorial)
1.19. Duman S, Asci G, Toz H, Ozkahya M, Ertilav M, Sezis M, Ok E. Patients with failed renal transplant may be suitable for peritoneal dialysis. Int Urol Nephrol. 2004;36(2):249-252.
1.20. Duman S, Wieczorowska-Tobis K, Styszynski A, Kwiatkowska B, Breborowicz A, Oreopoulos DG. Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum. Adv Perit Dial. 2004;20:31-36. n
1.21. Duman S; Sen, S; Sozmen, EY; Oreopoulos D.G . Atorvastatin improves peritoneal sclerosis induced by hypertonic PD solution in rats. Int J Artif Organs. 2005, 28 (2): 170-176
1.22. Duman S, Sen S; Duman, C Oreopoulos D.G. Effect of valsartan versus lisinopril on peritoneal sclerosis in rats. Int J Artif Organs. 2005, 28 (2): 156-163
1.23. Alper S, Kýlýnç I, Duman S, Töz H, Ceylan C, Ünal Ý, Aytimur D. Skin Disease in Turkish renal transplant recipients. International Journal of Dermatology 2005, 44:939-941
1.24. Atasever A, Bacakoglu F, Toz H, Basoglu OK, Duman S, Basak K, Guzelant A, Sayiner A. Tuberculosis in renal transplant recipients on various immunosuppressive regimens. Nephrol Dial Transplant. 2005 Apr;20(4):797-802.
1.25. Aþci G, Ozkahya M, Duman S, Toz H, Erten S, Ok E. Volume control associated with better cardiac function in long-term peritoneal dialysis patients. Perit Dial Int. 2006 Jan-Feb;26(1):85-88.
1.26. Ozkahya M, Ok E, Toz H, Asci G, Duman S, Basci A, Kose T, Dorhout Mees EJ. Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant. 2006 Dec;21(12):3506-3513
1.27. Duman S, Ozbek SS, Gunay ES, Bozkurt D, Asci G, Sipahi S, Kirçelli F, Ertilav M, Ozkahya M, Ok E. What does peritoneal thickness in peritoneal dialysis patients tell us? Adv Perit Dial. 2007;23:28-33.
1.28. Asci G, Basci A, Shah SV, Basnakian A, Toz H, Ozkahya M, Duman S, Ok E. Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells. Nephrology (Carlton). 20